Influence of medetomidine on stress-related neurohormonal and metabolic effects caused by butorphanol, fentanyl, and ketamine administration in dogs

被引:47
作者
Ambrisko, TD [1 ]
Hikasa, Y [1 ]
Sato, K [1 ]
机构
[1] Tottori Univ, Fac Agr, Dept Vet Internal Med, Tottori 6808553, Japan
关键词
D O I
10.2460/ajvr.2005.66.406
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Objective-To examine stress-related neurohormonal and metabolic effects of butorphanol, fentanyl, and ketamine administration alone and in combination with medetomidine in dogs. Animals-10 Beagles. Procedure-5 dogs received either butorphanol (0.1 mg/kg), fentanyl (0.01 mg/kg), or ketamine (10 mg/kg) IM in a crossover design. Another 5 dogs received either medetomidine (0.02 mg/kg) and butorphanol (0.1 mg/kg), medetomidine and fentanyl (0.01 mg/kg), medetomidine and ketamine (10 mg/kg), or medetomidine and saline (0.9% NaCl) solution (0.1 mL/kg) in a similar design. Blood samples were obtained for 6 hours following the treatments. Norepinephrine, epinephrine, cortisol, glucose, insulin, and nonesterified fatty acid concentrations were determined in plasma. Results-Administration of butorphanol, fentanyl, and ketamine caused neurchormonal and metabolic changes similar to stress, including increased plasma epinephrine, cortisol, and glucose concentrations. The hyperglycemic effect of butorphanol was not significant. Ketamine caused increased norepinephrine concentration. Epinephrine concentration was correlated with glucose concentration in the butorphanol and fentanyl groups but not in the ketamine groups, suggesting an important difference between the mechanisms of the hyperglycemic effects of these drugs. Medetomidine prevented most of these effects except for hyperglycemia. Plasma glucose concentrations were lower in the combined sedation groups than in the medetomidine-saline solution group. Conclusions and Clinical Relevance-Opioids or ketamine used alone may cause changes in stress-related biochemical variables in plasma. Medetomidine prevented or blunted these changes. Combined sedation provided better hormonal and metabolic stability than either component alone. We recommend using medetomidine-butorphanol or medetomidine-ketamine combinations for sedation or anesthesia of systemically healthy dogs.
引用
收藏
页码:406 / 412
页数:7
相关论文
共 30 条
[1]  
Adamson C, 1997, Md Med J, V46, P530
[2]  
Ambrisko TD, 2003, CAN J VET RES, V67, P64
[3]  
Ambrisko TD, 2002, CAN J VET RES, V66, P42
[4]  
BARAKA A, 1973, ANESTH ANALG, V52, P198
[5]   Perioperative stress response in the dog: Effect of pre-emptive administration of medetomidine [J].
Benson, GJ ;
Grubb, TL ;
Neff-Davis, C ;
Olson, WA ;
Thurmon, JC ;
Lindner, DL ;
Tranquilli, WJ ;
Vanio, O .
VETERINARY SURGERY, 2000, 29 (01) :85-91
[6]   METHODOLOGICAL CONSIDERATIONS IN THE DETERMINATION OF PLASMA-CATECHOLAMINES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION [J].
BOULOUX, P ;
PERRETT, D ;
BESSER, GM .
ANNALS OF CLINICAL BIOCHEMISTRY, 1985, 22 (MAR) :194-203
[7]   The stress response to trauma and surgery [J].
Desborough, JP .
BRITISH JOURNAL OF ANAESTHESIA, 2000, 85 (01) :109-117
[8]  
DOENICKE A, 1992, ANAESTHESIST, V41, P597
[9]   HYPERGLYCEMIC EFFECT OF MORPHINE [J].
FELDBERG, W ;
SHALIGRAM, SV .
BRITISH JOURNAL OF PHARMACOLOGY, 1972, 46 (04) :602-618
[10]   MORPHINE HYPERGLYCEMIA [J].
FELDBERG, W ;
GUPTA, KP .
JOURNAL OF PHYSIOLOGY-LONDON, 1974, 238 (03) :487-502